מיכשור לטיפולים בבתי חולים
The IPV-1C is a versatile Flow Ventilation® solution built to provide lung conditioning therapy, which assists in the restoration of Functional Residual Capacity (FRC) by providing ventilation and airway clearance for most patient population
The IPV-2C
Designed specifically for hospital use and with the versatility to treat most patients, including those in the NICU, the IPV-2C provides Lung Conditioning Therapy, either invasively or noninvasively, for patients in all hospital units. Flow Ventilation enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron provides a lung protective strategy and also makes the IPV-2C compatible with conventional ventilators, preventing the need to switch between different devices. It also provides an added advantage of demand CPAP to reduce WOB while transitioning to Flow Ventilation, as well as independent CPAP for weaning.
- Restores FRC
- Reduces time in the ICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Reduces time in the ICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Portable
- Lightweight
- Additional control sensitivity
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators
- Demand CPAP
- Independent CPAP
- Often used with Phasitron Kit A50095-D
- Lightweight
- Additional control sensitivity
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators
- Demand CPAP
- Independent CPAP
- Often used with Phasitron Kit A50095-D
Pulmonary complications of:
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
Benefits:
Benefits:
Features:
The IPV-1C
Patients who may benefit include those with the following conditions:
Features:
- Portable
- Lightweight
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators
- Lightweight
- Pneumatically powered by hospital air or O2
- Compatible with most conventional ventilators
- COPD
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
Patients who may benefit include those with the following conditions:
Pulmonary complications of:
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
- Cystic Fibrosis
- Alpha-1
- SMA
- ALS
Designed specifically for hospital use, the IPV-1C is a Flow Ventilation device that is safe and provides Lung Conditioning Therapy for a wide range of patients. Flow Ventilation enables improved clearance of secretions while supporting lung recruitment and gas exchange. The Phasitron kit provides a lung protective strategy, and also makes the IPV-1C compatible with conventional ventilators, preventing the need to switch between different devices.
The benefits of the IPV-1C are safely available to patients of all ages.
The benefits of the IPV-1C are safely available to patients of all ages.
The IPV-2C enhances the clinical versatility of IPV therapy by providing added control, including demand CPAP to reduce work-of-breathing (WOB) while transitioning to Flow Ventilation, as well as independent CPAP for weaning.
- COPD
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
- Asthma
- Atelectasis
- Pneumonia
- Premature Lungs
- Bronchitis
- Restores FRC
- Reduces time in the ICU
- Reduces oxygen need at discharge from NICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Demand CPAP
- Reduces time in the ICU
- Reduces oxygen need at discharge from NICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Demand CPAP
טלפון:04-6293501 פקס: 077-8833305